PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024
PacBio (NASDAQ: PACB) has announced its upcoming third quarter 2024 financial results conference call, scheduled for Thursday, November 7, 2024, at 4:30 pm Eastern Time (1:30 pm Pacific Time). Investors and interested parties can access the webcast through PacBio's investor relations website at https://investor.pacificbiosciences.com/.
For those preferring a dial-in option, the following numbers are provided:
- Toll-free: 1-888-349-0136
- International: 1-412-317-0459
Participants using the dial-in option are advised to join the call ten minutes before the start time and ask to join the 'PacBio Q3 Earnings Call'. A replay of the webcast will be available on the company's investor relations website after the call.
PacBio (NASDAQ: PACB) ha annunciato la sua prossima teleconferenza per i risultati finanziari del terzo trimestre 2024, programmata per giovedì 7 novembre 2024, alle 16:30 ora orientale (alle 13:30 ora del Pacifico). Gli investitori e le parti interessate possono accedere alla trasmissione in diretta attraverso il sito web delle relazioni con gli investitori di PacBio all'indirizzo https://investor.pacificbiosciences.com/.
Per coloro che preferiscono un'opzione di chiamata, sono forniti i seguenti numeri:
- Numero verde: 1-888-349-0136
- Internazionale: 1-412-317-0459
I partecipanti che utilizzano l'opzione di chiamata sono invitati a unirsi alla chiamata dieci minuti prima dell'orario di inizio e a chiedere di partecipare alla 'PacBio Q3 Earnings Call'. Una registrazione della trasmissione sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda dopo la chiamata.
PacBio (NASDAQ: PACB) ha anunciado su próxima teleconferencia sobre los resultados financieros del tercer trimestre de 2024, programada para jueves 7 de noviembre de 2024, a las 4:30 pm hora del Este (1:30 pm hora del Pacífico). Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través del sitio web de relaciones con los inversores de PacBio en https://investor.pacificbiosciences.com/.
Para aquellos que prefieren una opción de llamada, se proporcionan los siguientes números:
- Llamada gratuita: 1-888-349-0136
- Internacional: 1-412-317-0459
Se aconseja a los participantes que utilicen la opción de llamada unirse a la llamada diez minutos antes de la hora de inicio y solicitar unirse a la 'PacBio Q3 Earnings Call'. Una grabación de la transmisión estará disponible en el sitio web de relaciones con los inversores de la empresa después de la llamada.
PacBio (NASDAQ: PACB)는 2024년 3분기 재무 결과에 대한 컨퍼런스 콜을 2024년 11월 7일 목요일 오후 4:30 동부 표준시 (오후 1:30 태평양 표준시)로 예정했다고 발표했습니다. 투자자 및 관심 있는 당사자는 https://investor.pacificbiosciences.com/의 PacBio 투자자 관계 웹사이트를 통해 웹캐스트에 접속할 수 있습니다.
전화 옵션을 선호하는 분들을 위해 다음 번호가 제공됩니다:
- 무료전화: 1-888-349-0136
- 국제전화: 1-412-317-0459
전화 옵션을 사용하는 참가자는 시작 시간 10분 전에 콜에 참여하고 'PacBio Q3 Earnings Call'에 참여해 달라고 요청하는 것이 좋습니다. 통화 후 회사의 투자자 관계 웹사이트에서 웹캐스트의 재생을 이용할 수 있습니다.
PacBio (NASDAQ: PACB) a annoncé sa prochaine conférence téléphonique pour les résultats financiers du troisième trimestre 2024, prévue pour jeudi 7 novembre 2024, à 16h30 heure de l'Est (13h30 heure du Pacifique). Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct via le site web des relations avec les investisseurs de PacBio à l'adresse https://investor.pacificbiosciences.com/.
Pour ceux qui préfèrent une option de connexion par téléphone, les numéros suivants sont fournis :
- Numéro vert : 1-888-349-0136
- International : 1-412-317-0459
Les participants utilisant l'option de connexion par téléphone sont invités à se joindre à l'appel dix minutes avant l'heure de début et à demander à participer à la 'PacBio Q3 Earnings Call'. Un enregistrement de la diffusion sera disponible sur le site web des relations avec les investisseurs de l'entreprise après l'appel.
PacBio (NASDAQ: PACB) hat seine bevorstehende Telefonkonferenz zu den Finanzergebnissen des dritten Quartals 2024 angekündigt, die für Donnerstag, den 7. November 2024, um 16:30 Uhr Eastern Time (13:30 Uhr Pacific Time) geplant ist. Investoren und Interessierte können über die Investor-Relations-Website von PacBio unter https://investor.pacificbiosciences.com/ auf das Webcast zugreifen.
Für diejenigen, die eine Einwahl-Option bevorzugen, sind die folgenden Nummern angegeben:
- Gebührenfrei: 1-888-349-0136
- International: 1-412-317-0459
Teilnehmer, die die Einwahl-Option nutzen, werden gebeten, zehn Minuten vor Beginn der Konferenz zu erscheinen und zu fragen, ob sie an der 'PacBio Q3 Earnings Call' teilnehmen können. Eine Wiederholung des Webcast wird nach dem Anruf auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on Thursday, November 7, 2024, at 4:30 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, November 7, 2024, at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
If using the dial-in option, please join the call ten minutes before the start time using the appropriate number above and ask to join the “PacBio Q3 Earnings Call.”
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When will PacBio (PACB) report its Q3 2024 financial results?
How can investors access PacBio's (PACB) Q3 2024 earnings call?
What time does PacBio's (PACB) Q3 2024 earnings call start in Pacific Time?
Will there be a replay available for PacBio's (PACB) Q3 2024 earnings call?
